HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

TRANSCENTA-B

0.850

-0.130-13.27%

Volume:2.03M

Turnover:1.78M

Market Cap:385.05M

PE:-1.73

High:0.980

Open:0.980

Low:0.780

Close:0.980

52wk High:5.800

52wk Low:0.780

Shares:453.00M

HK Float Shares:453.00M

Volume Ratio:2.62

T/O Rate:0.45%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.490

ROE:-26.76%

ROA:-9.62%

PB:0.60

PE(LYR):-1.73

PS:11.63

Loading ...

Overview Company News Filings

Transcenta Secures 7 Million Yuan Milestone Payment Under EirGenix Bio-Platform Deal; Shares Fall 7%

MT Newswires Live

Transcenta Receives RMB 7.00 Million HiCB Milestone, Bolsters CDMO Pipeline with New GMP Contracts

Bulletin Express

TRANSCENTA-B (06628) Announces Milestone Payment for HiCB Out-Licensing and Steady Growth in CDMO Operations

Transcenta Holding - Receipt of a Milestone Payment of RMB 7 Mln From Its Hicb Platform Out-Licensing

THOMSON REUTERS

Transcenta Holding Ltd - Negotiating Contracts for Ind Development and Sirna Gmp DP Production

THOMSON REUTERS

Transcenta Says Ozekibart Found to Benefit Patients With Colorectal Cancer

MT Newswires Live

Partner Inhibrx Reports Positive CRC Data for Ozekibart and Submits US BLA for Chondrosarcoma Treatment

Transcenta Updates: Partner Inhibrx Posts 20% ORR for Ozekibart in Late-Line Colorectal Cancer, Files U.S. BLA for Chondrosarcoma

Bulletin Express

Transcenta partner Inhibrx reports 20% ORR in ozekibart colorectal cancer trial

Transcenta Holding announces postponed annual general meeting

天境生物2025年业绩：营收下滑至0.074亿元，净亏损收窄至2.037亿元，聚焦肿瘤与免疫管线进展

Bulletin Express

Transcenta Publishes 2025 Annual Report and ESG Report, Urges Shift to Digital Access

Bulletin Express

Transcenta Releases 2025 Annual and ESG Reports Online, Offers Free Printed Copies on Request

Bulletin Express

Transcenta publishes 2025 annual report

Transcenta publishes 2025 ESG report

Transcenta Therapeutics Presents New Data for Its Novel Liv1-Targeting ADC Tst013 Demonstrating Potent Anti-Tumor Activity in Pdx Models of Prostate Cancer and Er Positive /Her2 Negative Breast Cancer

THOMSON REUTERS

Transcenta Holding Ltd - ADC-2 Well Tolerated in Mice With Maximum Tolerated Dose of 60 Mg/Kg

THOMSON REUTERS

TRANSCENTA-B Reveals New Data Showing Potent Anti-Tumor Activity of Novel LIV1 ADC TST013 in Prostate Cancer and ER-Positive/HER2-Negative Breast Cancer PDX Models

TRANSCENTA-B presents robust preclinical results for LIV1-targeting ADC TST013 in prostate and ER+/HER2- breast cancers

Bulletin Express

Transcenta presents preclinical TST013 LIV1 ADC data in prostate, ER+/HER2- breast PDX models

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/06628/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"06628","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06628\",,,,,undefined,":{"symbol":"06628","market":"HK","secType":"STK","nameCN":"TRANSCENTA-B","latestPrice":0.85,"timestamp":1789027722256,"preClose":0.98,"halted":0,"volume":2033000,"delay":0,"changeRate":-0.1326530612244898,"floatShares":453000000,"shares":453000000,"eps":-0.49,"marketStatus":"Closed","change":-0.13,"latestTime":"09-10 16:08:42","open":0.98,"high":0.98,"low":0.78,"amount":1779005,"amplitude":0.204082,"askPrice":0.85,"askSize":1000,"bidPrice":0.83,"bidSize":36000,"shortable":0,"etf":0,"ttmEps":-0.41,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":5,"adr":0,"listingDate":1632844800000,"exchange":"SEHK","adjPreClose":0.98,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"volumeRatio":2.620859,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06628\",,,,,undefined,":{"symbol":"06628","floatShares":453000000,"roa":"-9.62%","roe":"-26.76%","lyrEps":-0.49,"volumeRatio":2.620859,"shares":453000000,"dividePrice":0,"high":0.98,"amplitude":0.204082,"preClose":0.98,"low":0.78,"week52Low":0.78,"pbRate":"0.60","psRate":"11.63","week52High":5.8,"institutionHeld":0,"latestPrice":0.85,"committee":0.945946,"eps":-0.49,"divideRate":0,"volume":2033000,"delay":0,"ttmEps":-0.41,"open":0.98,"prevYearClose":2.12,"prevWeekClose":1.025,"prevMonthClose":1.04,"prevQuarterClose":1.18,"fiveDayClose":1.01,"twentyDayClose":1.14,"sixtyDayClose":1.49},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06628\",params:#limit:5,,,undefined,":[{"date":"2026-08-28","symbol":"06628","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787880600000,"name":null,"time":"","dateTimestamp":1787846400000,"actualEps":null},{"date":"2026-03-30","symbol":"06628","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null},{"date":"2025-08-27","symbol":"06628","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756258200000,"name":null,"time":"","dateTimestamp":1756224000000,"actualEps":null},{"date":"2025-03-28","symbol":"06628","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743125400000,"name":null,"time":"Post-Mkt","dateTimestamp":1743091200000,"actualEps":null},{"market":"HK","date":"2024-08-28","symbol":"06628","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1724774400000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06628\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06628\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06628\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06628","date":"2026-09-09","current":-2.073171,"percent":0.455218,"low":-16.256284,"twenty":-3.601165,"median":-2.006405,"eighty":-1.172186,"high":-0.559575,"avg":-2.478331,"sd":1.542686,"marketCap":418112814},"quantilePoints":[{"date":"2021-09-30","current":-4.917522,"twenty":-16.251479,"median":-10.582899,"eighty":-4.584771,"marketCap":7125310672},{"date":"2021-10-08","current":-4.610388,"twenty":-9.449823,"median":-4.703759,"eighty":-4.628566,"marketCap":6679978755},{"date":"2021-10-15","current":-4.601084,"twenty":-4.856917,"median":-4.703759,"eighty":-4.61615,"marketCap":6671072116},{"date":"2021-10-22","current":-3.42164,"twenty":-4.755253,"median":-4.632739,"eighty":-3.879974,"marketCap":4996624108},{"date":"2021-10-29","current":-3.047978,"twenty":-4.733288,"median":-4.601084,"eighty":-3.347386,"marketCap":4439959212},{"date":"2021-11-05","current":-2.221943,"twenty":-4.71623,"median":-3.890035,"eighty":-3.051767,"marketCap":3242016355},{"date":"2021-11-12","current":-2.741709,"twenty":-4.701168,"median":-3.66388,"eighty":-2.554243,"marketCap":4016893891},{"date":"2021-11-19","current":-2.861262,"twenty":-4.674643,"median":-3.277613,"eighty":-2.70082,"marketCap":4186120019},{"date":"2021-11-26","current":-2.744715,"twenty":-4.634328,"median":-3.072471,"eighty":-2.695303,"marketCap":4016893891},{"date":"2021-12-03","current":-2.284054,"twenty":-4.619031,"median":-3.020868,"eighty":-2.524988,"marketCap":3348896015},{"date":"2021-12-10","current":-2.395382,"twenty":-4.606666,"median":-2.861262,"eighty":-2.37338,"marketCap":3518122144},{"date":"2021-12-17","current":-2.214985,"twenty":-4.394908,"median":-2.764013,"eighty":-2.325598,"marketCap":3250922994},{"date":"2021-12-24","current":-2.785793,"twenty":-4.027523,"median":-2.744784,"eighty":-2.289336,"marketCap":4092600317},{"date":"2021-12-31","current":-2.782771,"twenty":-3.920219,"median":-2.763927,"eighty":-2.295515,"marketCap":4097053636},{"date":"2022-01-07","current":-2.905719,"twenty":-2.842925,"median":-2.782817,"eighty":-2.734147,"marketCap":4261826445},{"date":"2022-01-14","current":-2.926672,"twenty":-2.924814,"median":-2.820094,"eighty":-2.771974,"marketCap":4301906318},{"date":"2022-01-21","current":-2.720485,"twenty":-2.912862,"median":-2.802903,"eighty":-2.751576,"marketCap":4007987253},{"date":"2022-01-28","current":-2.278933,"twenty":-2.904889,"median":-2.782794,"eighty":-2.670875,"marketCap":3348896015},{"date":"2022-02-04","current":-2.243667,"twenty":-2.904336,"median":-2.769274,"eighty":-2.446785,"marketCap":3295456185},{"date":"2022-02-11","current":-2.311765,"twenty":-2.875871,"median":-2.751547,"eighty":-2.278933,"marketCap":3402335845},{"date":"2022-02-18","current":-2.216156,"twenty":-2.851386,"median":-2.70008,"eighty":-2.244046,"marketCap":3277642909},{"date":"2022-02-25","current":-1.95239,"twenty":-2.837284,"median":-2.446785,"eighty":-2.228446,"marketCap":2894657460},{"date":"2022-03-04","current":-1.891592,"twenty":-2.802903,"median":-2.331274,"eighty":-2.20809,"marketCap":2805591077},{"date":"2022-03-11","current":-1.593746,"twenty":-2.790051,"median":-2.277718,"eighty":-1.95239,"marketCap":2360259160},{"date":"2022-03-18","current":-1.434075,"twenty":-2.782817,"median":-2.247604,"eighty":-1.831822,"marketCap":2115326605},{"date":"2022-03-25","current":-1.182018,"twenty":-2.782771,"median":-2.23729,"eighty":-1.625853,"marketCap":2493858735},{"date":"2022-04-01","current":-1.117366,"twenty":-2.755778,"median":-2.22771,"eighty":-1.46809,"marketCap":2360259160},{"date":"2022-04-08","current":-1.220141,"twenty":-2.752432,"median":-2.219284,"eighty":-1.235668,"marketCap":2578471799},{"date":"2022-04-14","current":-1.509233,"twenty":-2.751567,"median":-2.19544,"eighty":-1.253754,"marketCap":3184123206},{"date":"2022-04-22","current":-1.380956,"twenty":-2.739122,"median":-2.096927,"eighty":-1.280094,"marketCap":2859030907},{"date":"2022-04-29","current":-1.505435,"twenty":-2.712971,"median":-1.909464,"eighty":-1.280094,"marketCap":2605303485},{"date":"2022-05-06","current":-1.275668,"twenty":-2.701052,"median":-1.861634,"eighty":-1.264746,"marketCap":2189330660},{"date":"2022-05-13","current":-1.298908,"twenty":-2.698459,"median":-1.784469,"eighty":-1.241231,"marketCap":2189330660},{"date":"2022-05-20","current":-1.23226,"twenty":-2.6295,"median":-1.630386,"eighty":-1.241231,"marketCap":2106136094},{"date":"2022-05-27","current":-1.282048,"twenty":-2.446785,"median":-1.593746,"eighty":-1.239159,"marketCap":2189330660},{"date":"2022-06-02","current":-1.213994,"twenty":-2.418677,"median":-1.532529,"eighty":-1.233881,"marketCap":2084242788},{"date":"2022-06-10","current":-1.235049,"twenty":-2.362956,"median":-1.507334,"eighty":-1.231347,"marketCap":2106136094},{"date":"2022-06-17","current":-1.233834,"twenty":-2.319569,"median":-1.46809,"eighty":-1.233519,"marketCap":2101757433},{"date":"2022-06-24","current":-1.106047,"twenty":-2.285499,"median":-1.44033,"eighty":-1.221567,"marketCap":1891581690},{"date":"2022-06-30","current":-1.10026,"twenty":-2.278204,"median":-1.393033,"eighty":-1.217682,"marketCap":1878445706},{"date":"2022-07-08","current":-1.165743,"twenty":-2.266151,"median":-1.378742,"eighty":-1.19257,"marketCap":1992290900},{"date":"2022-07-15","current":-1.132686,"twenty":-2.254073,"median":-1.332616,"eighty":-1.181734,"marketCap":1917853658},{"date":"2022-07-22","current":-1.062165,"twenty":-2.246892,"median":-1.298908,"eighty":-1.165957,"marketCap":1799629802},{"date":"2022-07-29","current":-1.029897,"twenty":-2.243819,"median":-1.283448,"eighty":-1.154037,"marketCap":1747085866},{"date":"2022-08-05","current":-0.985946,"twenty":-2.239841,"median":-1.275668,"eighty":-1.132556,"marketCap":1668269962},{"date":"2022-08-12","current":-0.969099,"twenty":-2.234706,"median":-1.265902,"eighty":-1.114691,"marketCap":1641997995},{"date":"2022-08-19","current":-0.874482,"twenty":-2.230261,"median":-1.258574,"eighty":-1.100473,"marketCap":1466851542},{"date":"2022-08-26","current":-0.849893,"twenty":-2.227563,"median":-1.251783,"eighty":-1.092387,"marketCap":1414307606},{"date":"2022-09-02","current":-1.207026,"twenty":-2.224237,"median":-1.241231,"eighty":-1.094831,"marketCap":1269811782},{"date":"2022-09-09","current":-1.211639,"twenty":-2.218658,"median":-1.238164,"eighty":-1.098537,"marketCap":1269811782},{"date":"2022-09-16","current":-1.459086,"twenty":-2.21293,"median":-1.240001,"eighty":-1.097732,"marketCap":1515009896},{"date":"2022-09-23","current":-1.508984,"twenty":-2.19797,"median":-1.247604,"eighty":-1.100193,"marketCap":1536743398},{"date":"2022-09-30","current":-1.600207,"twenty":-2.180646,"median":-1.254494,"eighty":-1.100402,"marketCap":1632757637},{"date":"2022-10-07","current":-1.595956,"twenty":-2.145229,"median":-1.261029,"eighty":-1.100623,"marketCap":1628326331},{"date":"2022-10-14","current":-1.734039,"twenty":-2.003616,"median":-1.26681,"eighty":-1.101733,"marketCap":1750444528},{"date":"2022-10-21","current":-1.754281,"twenty":-1.943805,"median":-1.276301,"eighty":-1.106973,"marketCap":1758750530},{"date":"2022-10-28","current":-1.721959,"twenty":-1.90589,"median":-1.284847,"eighty":-1.112016,"marketCap":1723390010},{"date":"2022-11-04","current":-1.691691,"twenty":-1.8856,"median":-1.301959,"eighty":-1.117367,"marketCap":1709571438},{"date":"2022-11-11","current":-1.675151,"twenty":-1.855672,"median":-1.334018,"eighty":-1.120116,"marketCap":1707942923},{"date":"2022-11-18","current":-1.747804,"twenty":-1.822351,"median":-1.379849,"eighty":-1.131348,"marketCap":1775914166},{"date":"2022-11-25","current":-1.653564,"twenty":-1.783799,"median":-1.395959,"eighty":-1.132427,"marketCap":1666828529},{"date":"2022-12-02","current":-1.398955,"twenty":-1.776582,"median":-1.44033,"eighty":-1.132952,"marketCap":1434513986},{"date":"2022-12-09","current":-1.50327,"twenty":-1.757595,"median":-1.434075,"eighty":-1.137319,"marketCap":1555799425},{"date":"2022-12-16","current":-1.243503,"twenty":-1.753,"median":-1.412694,"eighty":-1.150732,"marketCap":1283952751},{"date":"2022-12-23","current":-1.339751,"twenty":-1.74786,"median":-1.390107,"eighty":-1.152224,"marketCap":1383762553},{"date":"2022-12-30","current":-1.245219,"twenty":-1.747818,"median":-1.379849,"eighty":-1.154401,"marketCap":1301750921},{"date":"2023-01-06","current":-1.232556,"twenty":-1.745814,"median":-1.366586,"eighty":-1.155489,"marketCap":1301750921},{"date":"2023-01-13","current":-1.154807,"twenty":-1.743004,"median":-1.344633,"eighty":-1.154999,"marketCap":1242962169},{"date":"2023-01-20","current":-1.188413,"twenty":-1.741529,"median":-1.334877,"eighty":-1.154999,"marketCap":1268157349},{"date":"2023-01-27","current":-1.192105,"twenty":-1.741205,"median":-1.332616,"eighty":-1.155127,"marketCap":1272356545},{"date":"2023-02-03","current":-1.144729,"twenty":-1.736307,"median":-1.30501,"eighty":-1.154585,"marketCap":1228119406},{"date":"2023-02-10","current":-1.13571,"twenty":-1.7349,"median":-1.301762,"eighty":-1.144729,"marketCap":1211121214},{"date":"2023-02-17","current":-1.009773,"twenty":-1.734039,"median":-1.298233,"eighty":-1.13571,"marketCap":1066636578},{"date":"2023-02-24","current":-1.00598,"twenty":-1.725783,"median":-1.279491,"eighty":-1.132362,"marketCap":1049638385},{"date":"2023-03-03","current":-0.950974,"twenty":-1.72297,"median":-1.269795,"eighty":-1.117366,"marketCap":998643808},{"date":"2023-03-10","current":-0.962295,"twenty":-1.035857,"median":-0.997908,"eighty":-0.983012,"marketCap":1003073230},{"date":"2023-03-17","current":-1.017689,"twenty":-2.303153,"median":-1.434075,"eighty":-1.133217,"marketCap":1071078195},{"date":"2023-03-24","current":-1.002144,"twenty":-2.289635,"median":-1.412694,"eighty":-1.122861,"marketCap":1066827885},{"date":"2023-03-31","current":-2.341613,"twenty":-2.289935,"median":-1.397457,"eighty":-1.116652,"marketCap":1088079436},{"date":"2023-04-06","current":-2.581098,"twenty":-2.321116,"median":-1.426434,"eighty":-1.117187,"marketCap":1198587504},{"date":"2023-04-14","current":-2.889441,"twenty":-2.352183,"median":-1.434075,"eighty":-1.117369,"marketCap":1343098054},{"date":"2023-04-21","current":-3.176719,"twenty":-2.394649,"median":-1.453428,"eighty":-1.125605,"marketCap":1475874065},{"date":"2023-04-28","current":-3.93421,"twenty":-2.45795,"median":-1.460591,"eighty":-1.131221,"marketCap":1814187442},{"date":"2023-05-05","current":-5.573577,"twenty":-2.519283,"median":-1.462354,"eighty":-1.131728,"marketCap":2574365925},{"date":"2023-05-12","current":-5.038304,"twenty":-2.644927,"median":-1.472002,"eighty":-1.132492,"marketCap":2311105082},{"date":"2023-05-19","current":-4.912378,"twenty":-2.711591,"median":-1.50327,"eighty":-1.133217,"marketCap":2221656425},{"date":"2023-05-25","current":-5.077547,"twenty":-2.726959,"median":-1.508984,"eighty":-1.134142,"marketCap":2286905317},{"date":"2023-06-02","current":-5.07414,"twenty":-2.74477,"median":-1.517837,"eighty":-1.134867,"marketCap":2277621427},{"date":"2023-06-09","current":-5.150356,"twenty":-2.762297,"median":-1.532529,"eighty":-1.136028,"marketCap":2308497282},{"date":"2023-06-16","current":-5.271556,"twenty":-2.785198,"median":-1.558152,"eighty":-1.137833,"marketCap":2351505510},{"date":"2023-06-23","current":-5.470364,"twenty":-2.802903,"median":-1.579194,"eighty":-1.139958,"marketCap":2426879193},{"date":"2023-06-30","current":-4.844138,"twenty":-2.862009,"median":-1.593746,"eighty":-1.143928,"marketCap":2129619768},{"date":"2023-07-07","current":-4.606135,"twenty":-2.904336,"median":-1.598091,"eighty":-1.144729,"marketCap":2021036602},{"date":"2023-07-14","current":-4.781468,"twenty":-2.944584,"median":-1.606603,"eighty":-1.15054,"marketCap":2127406950},{"date":"2023-07-21","current":-4.880654,"twenty":-3.02055,"median":-1.624708,"eighty":-1.151498,"marketCap":2161445461},{"date":"2023-07-28","current":-4.475558,"twenty":-3.164817,"median":-1.641934,"eighty":-1.154585,"marketCap":1979922893},{"date":"2023-08-04","current":-3.87303,"twenty":-3.216543,"median":-1.647433,"eighty":-1.154807,"marketCap":1716221372},{"date":"2023-08-11","current":-3.806723,"twenty":-3.42164,"median":-1.653564,"eighty":-1.155127,"marketCap":1677314591},{"date":"2023-08-18","current":-3.557482,"twenty":-3.731073,"median":-1.680685,"eighty":-1.15573,"marketCap":1556271270},{"date":"2023-08-25","current":-3.448655,"twenty":-3.729619,"median":-1.691691,"eighty":-1.157508,"marketCap":1633999758},{"date":"2023-09-01","current":-3.651789,"twenty":-3.66388,"median":-1.695453,"eighty":-1.159566,"marketCap":1737430065},{"date":"2023-09-08","current":-3.77339,"twenty":-3.766798,"median":-1.701788,"eighty":-1.159994,"marketCap":1774150199},{"date":"2023-09-15","current":-3.472893,"twenty":-3.733663,"median":-1.715927,"eighty":-1.162928,"marketCap":1645524333},{"date":"2023-09-22","current":-3.417047,"twenty":-3.731073,"median":-1.717132,"eighty":-1.163051,"marketCap":1611984367},{"date":"2023-09-29","current":-3.531726,"twenty":-3.729619,"median":-1.721347,"eighty":-1.165743,"marketCap":1668941473},{"date":"2023-10-06","current":-3.496303,"twenty":-3.677028,"median":-1.724376,"eighty":-1.166029,"marketCap":1651411300},{"date":"2023-10-13","current":-3.543667,"twenty":-3.654207,"median":-1.7349,"eighty":-1.169782,"marketCap":1671282416},{"date":"2023-10-20","current":-3.434493,"twenty":-3.651691,"median":-1.74161,"eighty":-1.172959,"marketCap":1617297234},{"date":"2023-10-27","current":-3.505876,"twenty":-3.615929,"median":-1.746146,"eighty":-1.173719,"marketCap":1650203300},{"date":"2023-11-03","current":-3.513866,"twenty":-3.581681,"median":-1.754281,"eighty":-1.17457,"marketCap":1658355826},{"date":"2023-11-10","current":-3.226077,"twenty":-3.564382,"median":-1.782795,"eighty":-1.178804,"marketCap":1522216604},{"date":"2023-11-17","current":-2.980352,"twenty":-3.556931,"median":-1.861634,"eighty":-1.181734,"marketCap":1418954678},{"date":"2023-11-24","current":-2.929924,"twenty":-3.552058,"median":-1.930927,"eighty":-1.182707,"marketCap":1406430033},{"date":"2023-12-01","current":-3.200234,"twenty":-3.547925,"median":-2.166745,"eighty":-1.18321,"marketCap":1542554865},{"date":"2023-12-08","current":-3.26477,"twenty":-3.545133,"median":-2.194206,"eighty":-1.183618,"marketCap":1567301735},{"date":"2023-12-15","current":-2.588278,"twenty":-3.54371,"median":-2.208829,"eighty":-1.184283,"marketCap":1249716909},{"date":"2023-12-22","current":-2.230997,"twenty":-3.543545,"median":-2.216207,"eighty":-1.186722,"marketCap":1076488823},{"date":"2023-12-29","current":-3.082963,"twenty":-3.543259,"median":-2.216786,"eighty":-1.188215,"marketCap":1495506493},{"date":"2024-01-05","current":-3.027023,"twenty":-3.542441,"median":-2.221943,"eighty":-1.188413,"marketCap":1458014687},{"date":"2024-01-12","current":-3.440326,"twenty":-3.535215,"median":-2.22771,"eighty":-1.192105,"marketCap":1657970987},{"date":"2024-01-19","current":-3.116133,"twenty":-3.531726,"median":-2.232983,"eighty":-1.194332,"marketCap":1499672250},{"date":"2024-01-26","current":-2.954111,"twenty":-3.527572,"median":-2.243856,"eighty":-1.195887,"marketCap":1416164448},{"date":"2024-02-02","current":-2.600144,"twenty":-3.521158,"median":-2.249969,"eighty":-1.19837,"marketCap":1244887922},{"date":"2024-02-09","current":-2.561354,"twenty":-3.513866,"median":-2.25426,"eighty":-1.200118,"marketCap":1232355493},{"date":"2024-02-16","current":-2.343783,"twenty":-3.509072,"median":-2.258439,"eighty":-1.200393,"marketCap":1127918587},{"date":"2024-02-23","current":-2.024591,"twenty":-3.505677,"median":-2.257801,"eighty":-1.202754,"marketCap":969174490},{"date":"2024-03-01","current":-2.127984,"twenty":-3.504968,"median":-2.251162,"eighty":-1.204921,"marketCap":1019304205},{"date":"2024-03-08","current":-1.82193,"twenty":-3.499615,"median":-2.246149,"eighty":-1.206374,"marketCap":873092536},{"date":"2024-03-15","current":-1.736293,"twenty":-3.493548,"median":-2.23729,"eighty":-1.208977,"marketCap":831317773},{"date":"2024-03-22","current":-1.895078,"twenty":-3.488578,"median":-2.231773,"eighty":-1.210396,"marketCap":906512346},{"date":"2024-03-28","current":-1.73465,"twenty":-3.484614,"median":-2.22771,"eighty":-1.210941,"marketCap":868915060},{"date":"2024-04-05","current":-1.577236,"twenty":-3.481801,"median":-2.222412,"eighty":-1.211639,"marketCap":789543011},{"date":"2024-04-12","current":-1.159319,"twenty":-3.481622,"median":-2.219247,"eighty":-1.211639,"marketCap":580669198},{"date":"2024-04-19","current":-1.402388,"twenty":-3.476821,"median":-2.216156,"eighty":-1.210475,"marketCap":701816010},{"date":"2024-04-26","current":-1.448263,"twenty":-3.474087,"median":-2.20846,"eighty":-1.211639,"marketCap":723879969},{"date":"2024-05-03","current":-1.473071,"twenty":-3.473132,"median":-2.194206,"eighty":-1.212787,"marketCap":735770683},{"date":"2024-05-10","current":-1.53406,"twenty":-3.471422,"median":-2.174051,"eighty":-1.21381,"marketCap":768052794},{"date":"2024-05-17","current":-1.479052,"twenty":-3.457615,"median":-2.127984,"eighty":-1.21552,"marketCap":739425304},{"date":"2024-05-24","current":-1.440154,"twenty":-3.443658,"median":-2.050658,"eighty":-1.216902,"marketCap":718334392},{"date":"2024-05-31","current":-1.445896,"twenty":-3.436826,"median":-2.03887,"eighty":-1.217233,"marketCap":721932649},{"date":"2024-06-07","current":-1.349324,"twenty":-3.433957,"median":-2.020507,"eighty":-1.218016,"marketCap":672878742},{"date":"2024-06-14","current":-1.186976,"twenty":-3.433276,"median":-1.957949,"eighty":-1.217774,"marketCap":591376854},{"date":"2024-06-21","current":-1.148575,"twenty":-3.430506,"median":-1.909464,"eighty":-1.213442,"marketCap":571046672},{"date":"2024-06-28","current":-1.237883,"twenty":-3.4265,"median":-1.881728,"eighty":-1.210941,"marketCap":615193612},{"date":"2024-07-05","current":-1.229637,"twenty":-3.425359,"median":-1.862376,"eighty":-1.211926,"marketCap":610962821},{"date":"2024-07-12","current":-1.194759,"twenty":-3.42375,"median":-1.831822,"eighty":-1.205828,"marketCap":594504955},{"date":"2024-07-19","current":-1.194546,"twenty":-3.421536,"median":-1.791461,"eighty":-1.201303,"marketCap":594410140},{"date":"2024-07-26","current":-1.059661,"twenty":-3.421044,"median":-1.781121,"eighty":-1.19615,"marketCap":529250008},{"date":"2024-08-02","current":-1.044091,"twenty":-3.420207,"median":-1.751078,"eighty":-1.19255,"marketCap":521169855},{"date":"2024-08-09","current":-1.125222,"twenty":-3.417857,"median":-1.744488,"eighty":-1.188215,"marketCap":565410496},{"date":"2024-08-16","current":-1.116751,"twenty":-3.416591,"median":-1.738984,"eighty":-1.183365,"marketCap":561371849},{"date":"2024-08-23","current":-1.10405,"twenty":-3.405129,"median":-1.736293,"eighty":-1.180781,"marketCap":557333203},{"date":"2024-08-30","current":-1.383726,"twenty":-3.365941,"median":-1.73444,"eighty":-1.174089,"marketCap":545217264},{"date":"2024-09-06","current":-1.369992,"twenty":-3.362986,"median":-1.729148,"eighty":-1.17617,"marketCap":540065399},{"date":"2024-09-13","current":-1.239095,"twenty":-3.361169,"median":-1.722465,"eighty":-1.180781,"marketCap":487185852},{"date":"2024-09-20","current":-1.064481,"twenty":-3.359971,"median":-1.720717,"eighty":-1.173523,"marketCap":421041357},{"date":"2024-09-27","current":-1.039101,"twenty":-3.336948,"median":-1.716885,"eighty":-1.1661,"marketCap":413474298},{"date":"2024-10-04","current":-1.366635,"twenty":-3.327204,"median":-1.715884,"eighty":-1.166029,"marketCap":541335155},{"date":"2024-10-10","current":-1.173744,"twenty":-3.324285,"median":-1.701788,"eighty":-1.165957,"marketCap":461918833},{"date":"2024-10-18","current":-1.051511,"twenty":-3.318884,"median":-1.695453,"eighty":-1.163002,"marketCap":411657168},{"date":"2024-10-25","current":-1.051451,"twenty":-3.304929,"median":-1.691691,"eighty":-1.159467,"marketCap":411607698},{"date":"2024-11-01","current":-1.044465,"twenty":-3.293084,"median":-1.680685,"eighty":-1.154999,"marketCap":409148433},{"date":"2024-11-08","current":-0.989918,"twenty":-3.287374,"median":-1.660464,"eighty":-1.153671,"marketCap":384842586},{"date":"2024-11-15","current":-0.923732,"twenty":-3.273142,"median":-1.654305,"eighty":-1.147862,"marketCap":356397763},{"date":"2024-11-22","current":-0.80838,"twenty":-3.260314,"median":-1.651237,"eighty":-1.138896,"marketCap":311744478},{"date":"2024-11-29","current":-0.756222,"twenty":-3.254147,"median":-1.64407,"eighty":-1.134399,"marketCap":291434730},{"date":"2024-12-06","current":-0.705368,"twenty":-3.250832,"median":-1.641934,"eighty":-1.131221,"marketCap":271196207},{"date":"2024-12-13","current":-0.642435,"twenty":-3.244963,"median":-1.630115,"eighty":-1.122167,"marketCap":246775169},{"date":"2024-12-20","current":-0.698931,"twenty":-3.239432,"median":-1.619291,"eighty":-1.11664,"marketCap":267002642},{"date":"2024-12-27","current":-0.604091,"twenty":-3.23731,"median":-1.604528,"eighty":-1.115419,"marketCap":230593191},{"date":"2025-01-03","current":-0.614088,"twenty":-3.234542,"median":-1.598091,"eighty":-1.106887,"marketCap":234638686},{"date":"2025-01-10","current":-0.648307,"twenty":-3.228459,"median":-1.593746,"eighty":-1.103566,"marketCap":246775169},{"date":"2025-01-17","current":-0.658404,"twenty":-3.226077,"median":-1.579194,"eighty":-1.100615,"marketCap":250820664},{"date":"2025-01-24","current":-0.601538,"twenty":-3.218952,"median":-1.571907,"eighty":-1.096121,"marketCap":230593191},{"date":"2025-01-28","current":-0.577673,"twenty":-3.218945,"median":-1.544396,"eighty":-1.092133,"marketCap":222502202},{"date":"2025-02-07","current":-0.63348,"twenty":-3.218438,"median":-1.537783,"eighty":-1.089513,"marketCap":242729675},{"date":"2025-02-14","current":-0.740256,"twenty":-3.217233,"median":-1.53406,"eighty":-1.084478,"marketCap":282965171},{"date":"2025-02-21","current":-0.936049,"twenty":-3.216505,"median":-1.523783,"eighty":-1.073999,"marketCap":359770003},{"date":"2025-02-28","current":-1.55117,"twenty":-3.209962,"median":-1.524436,"eighty":-1.073999,"marketCap":594226859},{"date":"2025-03-07","current":-1.881287,"twenty":-3.199289,"median":-1.528482,"eighty":-1.076841,"marketCap":723582366},{"date":"2025-03-14","current":-1.554912,"twenty":-3.197754,"median":-1.535095,"eighty":-1.079544,"marketCap":598269219},{"date":"2025-03-21","current":-2.102058,"twenty":-3.189234,"median":-1.534578,"eighty":-1.083365,"marketCap":808471918},{"date":"2025-03-28","current":-1.916751,"twenty":-3.174206,"median":-1.540393,"eighty":-1.084478,"marketCap":735709445},{"date":"2025-04-03","current":-1.79495,"twenty":-3.169797,"median":-1.544396,"eighty":-1.084622,"marketCap":557845623},{"date":"2025-04-11","current":-1.548672,"twenty":-3.166755,"median":-1.54098,"eighty":-1.084783,"marketCap":476998431},{"date":"2025-04-17","current":-1.507301,"twenty":-3.164817,"median":-1.54098,"eighty":-1.085427,"marketCap":464871352},{"date":"2025-04-25","current":-1.569796,"twenty":-3.163451,"median":-1.546534,"eighty":-1.088401,"marketCap":485083150},{"date":"2025-05-02","current":-1.638198,"twenty":-3.161167,"median":-1.553041,"eighty":-1.089697,"marketCap":507296013},{"date":"2025-05-09","current":-1.496635,"twenty":-3.154883,"median":-1.55831,"eighty":-1.090108,"marketCap":466712332},{"date":"2025-05-16","current":-1.381237,"twenty":-3.138488,"median":-1.548672,"eighty":-1.090564,"marketCap":434245387},{"date":"2025-05-23","current":-1.99489,"twenty":-3.121526,"median":-1.549921,"eighty":-1.091341,"marketCap":629047057},{"date":"2025-05-30","current":-2.075856,"twenty":-3.115819,"median":-1.561707,"eighty":-1.092133,"marketCap":657455633},{"date":"2025-06-06","current":-1.904416,"twenty":-3.115045,"median":-1.570851,"eighty":-1.094186,"marketCap":604696848},{"date":"2025-06-13","current":-2.069755,"twenty":-3.111613,"median":-1.57844,"eighty":-1.097719,"marketCap":657455633},{"date":"2025-06-20","current":-1.830593,"twenty":-3.102235,"median":-1.588932,"eighty":-1.100128,"marketCap":580346639},{"date":"2025-06-27","current":-1.863778,"twenty":-3.093588,"median":-1.595975,"eighty":-1.100193,"marketCap":592521744},{"date":"2025-07-04","current":-1.914751,"twenty":-3.091398,"median":-1.598193,"eighty":-1.100331,"marketCap":608755216},{"date":"2025-07-11","current":-2.087481,"twenty":-3.090247,"median":-1.604528,"eighty":-1.100623,"marketCap":663002490},{"date":"2025-07-18","current":-2.458535,"twenty":-3.08847,"median":-1.613926,"eighty":-1.100988,"marketCap":780240735},{"date":"2025-07-25","current":-3.566555,"twenty":-3.094231,"median":-1.624708,"eighty":-1.102403,"marketCap":1135998168},{"date":"2025-08-01","current":-3.639814,"twenty":-3.115976,"median":-1.634919,"eighty":-1.102908,"marketCap":1152168961},{"date":"2025-08-08","current":-3.949531,"twenty":-3.162462,"median":-1.641716,"eighty":-1.103663,"marketCap":1253335614},{"date":"2025-08-15","current":-4.338243,"twenty":-3.175462,"median":-1.643622,"eighty":-1.10405,"marketCap":1374626157},{"date":"2025-08-22","current":-5.06222,"twenty":-3.213204,"median":-1.650792,"eighty":-1.104449,"marketCap":1598997035},{"date":"2025-08-29","current":-4.571139,"twenty":-3.218948,"median":-1.654305,"eighty":-1.106215,"marketCap":1331144740},{"date":"2025-09-05","current":-6.737958,"twenty":-3.23731,"median":-1.656723,"eighty":-1.107645,"marketCap":1960191797},{"date":"2025-09-12","current":-7.048304,"twenty":-3.256278,"median":-1.663693,"eighty":-1.110965,"marketCap":2054168159},{"date":"2025-09-19","current":-6.649948,"twenty":-3.296283,"median":-1.672776,"eighty":-1.112748,"marketCap":1936695160},{"date":"2025-09-26","current":-6.313418,"twenty":-3.324607,"median":-1.675151,"eighty":-1.115419,"marketCap":1833915564},{"date":"2025-10-03","current":-7.147434,"twenty":-3.361468,"median":-1.69027,"eighty":-1.11588,"marketCap":2081134574},{"date":"2025-10-10","current":-6.106601,"twenty":-3.415221,"median":-1.693057,"eighty":-1.116354,"marketCap":1775481980},{"date":"2025-10-17","current":-5.523431,"twenty":-3.421223,"median":-1.695453,"eighty":-1.116695,"marketCap":1604676119},{"date":"2025-10-24","current":-4.733384,"twenty":-3.428223,"median":-1.701788,"eighty":-1.117243,"marketCap":1375650536},{"date":"2025-10-31","current":-4.74178,"twenty":-3.436826,"median":-1.715884,"eighty":-1.117369,"marketCap":1380146126},{"date":"2025-11-07","current":-4.389275,"twenty":-3.473371,"median":-1.717008,"eighty":-1.118684,"marketCap":1276747557},{"date":"2025-11-14","current":-4.623456,"twenty":-3.483676,"median":-1.720699,"eighty":-1.122167,"marketCap":1348676997},{"date":"2025-11-21","current":-4.0397,"twenty":-3.504968,"median":-1.722465,"eighty":-1.124136,"marketCap":1177844577},{"date":"2025-11-28","current":-4.181809,"twenty":-3.523724,"median":-1.729148,"eighty":-1.124849,"marketCap":1223707597},{"date":"2025-12-05","current":-4.143936,"twenty":-3.54285,"median":-1.73444,"eighty":-1.128746,"marketCap":1214709747},{"date":"2025-12-12","current":-4.013728,"twenty":-3.547925,"median":-1.736293,"eighty":-1.131221,"marketCap":1178718347},{"date":"2025-12-19","current":-3.362382,"twenty":-3.547925,"median":-1.738984,"eighty":-1.131939,"marketCap":989763497},{"date":"2025-12-24","current":-3.306233,"twenty":-3.546492,"median":-1.742014,"eighty":-1.132427,"marketCap":976266722},{"date":"2026-01-02","current":-3.414683,"twenty":-3.543774,"median":-1.747804,"eighty":-1.132686,"marketCap":1012258122},{"date":"2026-01-09","current":-3.678697,"twenty":-3.547171,"median":-1.756352,"eighty":-1.134014,"marketCap":1093238772},{"date":"2026-01-16","current":-3.651692,"twenty":-3.557482,"median":-1.77285,"eighty":-1.134656,"marketCap":1088739847},{"date":"2026-01-23","current":-3.307803,"twenty":-3.557482,"median":-1.783008,"eighty":-1.135596,"marketCap":985264572},{"date":"2026-01-30","current":-3.578423,"twenty":-3.566555,"median":-1.794734,"eighty":-1.13571,"marketCap":1070744147},{"date":"2026-02-06","current":-3.614362,"twenty":-3.574732,"median":-1.798047,"eighty":-1.137302,"marketCap":1084240922},{"date":"2026-02-13","current":-3.578808,"twenty":-3.578423,"median":-1.82193,"eighty":-1.139958,"marketCap":1079741997},{"date":"2026-02-20","current":-3.464505,"twenty":-3.577098,"median":-1.825481,"eighty":-1.141546,"marketCap":1043750597},{"date":"2026-02-27","current":-3.412151,"twenty":-3.578654,"median":-1.831208,"eighty":-1.144248,"marketCap":1039251672},{"date":"2026-03-06","current":-3.305861,"twenty":-3.577098,"median":-1.841492,"eighty":-1.145554,"marketCap":998761347},{"date":"2026-03-13","current":-3.483403,"twenty":-3.577098,"median":-1.858915,"eighty":-1.147505,"marketCap":1057247372},{"date":"2026-03-20","current":-3.422246,"twenty":-3.577098,"median":-1.863118,"eighty":-1.149361,"marketCap":1034752747},{"date":"2026-03-27","current":-3.803908,"twenty":-3.577098,"median":-1.863735,"eighty":-1.150923,"marketCap":1147225872},{"date":"2026-04-02","current":-4.186555,"twenty":-3.591565,"median":-1.874534,"eighty":-1.151859,"marketCap":1268696847},{"date":"2026-04-10","current":-5.393187,"twenty":-3.599478,"median":-1.881287,"eighty":-1.152944,"marketCap":1259698997},{"date":"2026-04-17","current":-5.102124,"twenty":-3.623785,"median":-1.891567,"eighty":-1.153793,"marketCap":1192215122},{"date":"2026-04-24","current":-4.639782,"twenty":-3.644855,"median":-1.904416,"eighty":-1.154451,"marketCap":1084240922},{"date":"2026-04-30","current":-4.292141,"twenty":-3.654097,"median":-1.911608,"eighty":-1.154693,"marketCap":1003260272},{"date":"2026-05-08","current":-4.085489,"twenty":-3.673359,"median":-1.915751,"eighty":-1.15479,"marketCap":958271022},{"date":"2026-05-15","current":-3.425203,"twenty":-3.730121,"median":-1.920203,"eighty":-1.154999,"marketCap":805510872},{"date":"2026-05-22","current":-3.542034,"twenty":-3.699066,"median":-1.937708,"eighty":-1.155489,"marketCap":831082646},{"date":"2026-05-29","current":-2.863027,"twenty":-3.675139,"median":-1.948879,"eighty":-1.156441,"marketCap":674100251},{"date":"2026-06-05","current":-2.768407,"twenty":-3.667433,"median":-1.95239,"eighty":-1.158232,"marketCap":652767965},{"date":"2026-06-12","current":-2.697855,"twenty":-3.661611,"median":-1.97196,"eighty":-1.159418,"marketCap":635702136},{"date":"2026-06-18","current":-2.692171,"twenty":-3.658077,"median":-1.989104,"eighty":-1.159652,"marketCap":635702136},{"date":"2026-06-26","current":-2.01484,"twenty":-3.656404,"median":-2.01484,"eighty":-1.160436,"marketCap":473576759},{"date":"2026-07-03","current":-2.339822,"twenty":-3.651789,"median":-2.016423,"eighty":-1.162203,"marketCap":550372990},{"date":"2026-07-10","current":-1.943166,"twenty":-3.651692,"median":-2.006985,"eighty":-1.162928,"marketCap":456510930},{"date":"2026-07-17","current":-1.845796,"twenty":-3.651666,"median":-1.999131,"eighty":-1.163051,"marketCap":435178643},{"date":"2026-07-24","current":-2.044393,"twenty":-3.643152,"median":-2.006985,"eighty":-1.163161,"marketCap":482109673},{"date":"2026-07-31","current":-1.950228,"twenty":-3.641229,"median":-1.995424,"eighty":-1.164809,"marketCap":460777387},{"date":"2026-08-07","current":-2.009528,"twenty":-3.640001,"median":-1.983317,"eighty":-1.165639,"marketCap":475709987},{"date":"2026-08-14","current":-1.943988,"twenty":-3.637041,"median":-1.995424,"eighty":-1.166029,"marketCap":460777387},{"date":"2026-08-21","current":-1.957661,"twenty":-3.623785,"median":-1.983317,"eighty":-1.169483,"marketCap":465043844},{"date":"2026-08-28","current":-1.930284,"twenty":-3.615618,"median":-1.989104,"eighty":-1.170628,"marketCap":458644158},{"date":"2026-09-04","current":-2.323844,"twenty":-3.604462,"median":-1.999131,"eighty":-1.171177,"marketCap":437311872},{"date":"2026-09-09","current":-2.218272,"twenty":-3.601165,"median":-2.006405,"eighty":-1.172186,"marketCap":418112814}],"updateTime":1789041774897},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06628\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2638573931","title":"Transcenta Secures 7 Million Yuan Milestone Payment Under EirGenix Bio-Platform Deal; Shares Fall 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638573931","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638573931?lang=en_us&edition=fundamental","pubTime":"2026-05-27 11:50","pubTimestamp":1779853843,"startTime":"0","endTime":"0","summary":"Transcenta  received a 7 million yuan milestone payment tied to the out-licensing of its highly intensified continuous bioprocessing platform, according to a Tuesday Hong Kong bourse filing.Shares of the biopharmaceutical company were down over 7% in late morning trade on Wednesday.The payment followed progress under the company's collaboration and non-exclusive licensing agreement with EirGenix .","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","06628"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193091882","title":"Transcenta Receives RMB 7.00 Million HiCB Milestone, Bolsters CDMO Pipeline with New GMP Contracts","url":"https://stock-news.laohu8.com/highlight/detail?id=1193091882","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193091882?lang=en_us&edition=fundamental","pubTime":"2026-05-26 16:43","pubTimestamp":1779785008,"startTime":"0","endTime":"0","summary":"Transcenta Holding Limited (Transcenta) has secured a RMB 7.00 million milestone payment under its non-exclusive HiCB (highly intensified continuous bioprocessing) licensing agreement with...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06628"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173502698","title":"TRANSCENTA-B (06628) Announces Milestone Payment for HiCB Out-Licensing and Steady Growth in CDMO Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=1173502698","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173502698?lang=en_us&edition=fundamental","pubTime":"2026-05-26 16:38","pubTimestamp":1779784712,"startTime":"0","endTime":"0","summary":"TRANSCENTA-B (06628) has announced that the company has received a milestone payment of RMB 7 million from the out-licensing of its HiCB (High-Intensity Continuous Bioprocessing) platform, while its...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06628","BK1515","CDMO","BK1574","159938","BK1161","09939","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638928945","title":"Transcenta Holding -  Receipt of a Milestone Payment of RMB 7 Mln From Its Hicb Platform Out-Licensing","url":"https://stock-news.laohu8.com/highlight/detail?id=2638928945","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638928945?lang=en_us&edition=fundamental","pubTime":"2026-05-26 16:32","pubTimestamp":1779784378,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nFWN4220AS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06628","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638928755","title":"Transcenta Holding Ltd - Negotiating Contracts for Ind Development and Sirna Gmp DP Production","url":"https://stock-news.laohu8.com/highlight/detail?id=2638928755","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638928755?lang=en_us&edition=fundamental","pubTime":"2026-05-26 16:32","pubTimestamp":1779784378,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nFWN4220AS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06628","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637080383","title":"Transcenta Says Ozekibart Found to Benefit Patients With Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2637080383","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637080383?lang=en_us&edition=fundamental","pubTime":"2026-05-21 10:29","pubTimestamp":1779330541,"startTime":"0","endTime":"0","summary":"Transcenta  said updated data from the phase 1/2 study of ozekibart found the drug benefited patients with colorectal cancer and kept the disease at bay, according to a Thursday filing with the Hong Kong bourse.The firm holds a license to develop and commercialize the drug in the greater China region.Results published by the company's partner Inhibrx Biosciences showed the medicine had an objective response rate of 20% in patients who had been treated with other drugs previously.The median progression-free survival among the 45 evaluable patients from the trial was 5.5 months, while the overall disease control rate stood at 87%.Inhibrx plans to meet with the U.S. Food and Drug Administration in the second half of 2026 to discuss further trials of ozekibart in colorectal cancer.Meanwhile, Inhibrx submitted a biologics license application with the U.S. Food and Drug Administration seeking approval for ozekibart in conventional chondrosarcoma, a type of bone cancer.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["06628","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132270420","title":"Partner Inhibrx Reports Positive CRC Data for Ozekibart and Submits US BLA for Chondrosarcoma Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1132270420","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132270420?lang=en_us&edition=fundamental","pubTime":"2026-05-21 06:28","pubTimestamp":1779316114,"startTime":"0","endTime":"0","summary":"Partner Inhibrx Biosciences, Inc. has reported positive interim data from a Phase 1/2 study evaluating ozekibart in combination with FOLFIRI for patients with locally advanced or metastatic,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK4213","CRC","LU0266512127.USD","BK1574","LU0456854461.SGD","06628","159938","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146488393","title":"Transcenta Updates: Partner Inhibrx Posts 20% ORR for Ozekibart in Late-Line Colorectal Cancer, Files U.S. BLA for Chondrosarcoma","url":"https://stock-news.laohu8.com/highlight/detail?id=1146488393","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146488393?lang=en_us&edition=fundamental","pubTime":"2026-05-21 06:23","pubTimestamp":1779315786,"startTime":"0","endTime":"0","summary":"Transcenta Holding Limited (Transcenta) released a voluntary announcement highlighting two milestones from its U.S. partner, Inhibrx Biosciences (Inhibrx, Nasdaq: INBX): positive interim efficacy...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06628"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637879557","title":"Transcenta partner Inhibrx reports 20% ORR in ozekibart colorectal cancer trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2637879557","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637879557?lang=en_us&edition=fundamental","pubTime":"2026-05-21 06:21","pubTimestamp":1779315702,"startTime":"0","endTime":"0","summary":"Transcenta flagged a positive interim update from partner Inhibrx’s Phase 1/2 study of ozekibart combined with chemotherapy in advanced colorectal cancer; the results have already been reported as updated interim data with an April 10, 2026 cutoff.The update pointed to tumor shrinkage in some heavily pretreated patients, with broader disease stabilization and side effects described as manageable.Inhibrx also filed a U.S. biologics license application in April 2026 seeking approval of ozekibart for conventional chondrosarcoma, a cancer with no approved systemic treatment options.Transcenta holds Greater China rights to develop and commercialize ozekibart, prompting it to review regional plans following the U.S. regulatory filing and the colorectal cancer readout.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes onl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nNDL1yWHTr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06628"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635711436","title":"Transcenta Holding announces postponed annual general meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2635711436","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635711436?lang=en_us&edition=fundamental","pubTime":"2026-05-14 19:27","pubTimestamp":1778758069,"startTime":"0","endTime":"0","summary":"Transcenta set annual general meeting for June 30, 2026 in Hong Kong for fiscal 2025.Meeting was postponed from June 5 as company sought more preparation time.Share register closure reset to June 25–30 to determine shareholder eligibility to vote at AGM.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transcenta Holding Limited published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on May 14, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDL9z6l72:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06628","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145478450","title":"天境生物2025年业绩：营收下滑至0.074亿元，净亏损收窄至2.037亿元，聚焦肿瘤与免疫管线进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1145478450","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145478450?lang=en_us&edition=fundamental","pubTime":"2026-04-28 17:09","pubTimestamp":1777367391,"startTime":"0","endTime":"0","summary":"天境生物控股有限公司（Transcenta Holding...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"天境生物2025年业绩：营收下滑至0.074亿元，净亏损收窄至2.037亿元，聚焦肿瘤与免疫管线进展","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06628"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190957183","title":"Transcenta Publishes 2025 Annual Report and ESG Report, Urges Shift to Digital Access","url":"https://stock-news.laohu8.com/highlight/detail?id=1190957183","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190957183?lang=en_us&edition=fundamental","pubTime":"2026-04-28 17:06","pubTimestamp":1777367174,"startTime":"0","endTime":"0","summary":"Transcenta Holding Limited (TRANSCENTA-B) announced on 28 April 2026 that the English and Chinese versions of its 2025 Annual Report and 2025 Environmental, Social and Governance (ESG) Report have...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06628"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115524836","title":"Transcenta Releases 2025 Annual and ESG Reports Online, Offers Free Printed Copies on Request","url":"https://stock-news.laohu8.com/highlight/detail?id=1115524836","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115524836?lang=en_us&edition=fundamental","pubTime":"2026-04-28 17:05","pubTimestamp":1777367130,"startTime":"0","endTime":"0","summary":"Transcenta Holding Limited today announced that the English and Chinese versions of its 2025 Annual Report and 2025 Environmental, Social and Governance Report are now available on both the company’s...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06628"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630337913","title":"Transcenta publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2630337913","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630337913?lang=en_us&edition=fundamental","pubTime":"2026-04-28 17:01","pubTimestamp":1777366901,"startTime":"0","endTime":"0","summary":"Transcenta published 2025 annual report highlighting progress across oncology, immunology, osteoporosis programs.Lead asset osemitamab posted updated Phase I/II TranStar102 data in first-line G/GEJ cancer, supporting plan to start TranStar301 Phase III trial in 2026.Regulatory clearances for TranStar301 were secured from U.S. FDA, China CDE, South Korea MFDS, strengthening global development path.Strategic collaboration with EirGenix was signed to license HiCB continuous biomanufacturing platform, adding upfront, milestone, royalty-based economics.Management set 2026 priorities including at least USD 100 million funding target, tighter cost controls, sharper focus on osemitamab and blosozumab.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal adv","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDL3RYl1T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06628","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630799843","title":"Transcenta publishes 2025 ESG report","url":"https://stock-news.laohu8.com/highlight/detail?id=2630799843","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630799843?lang=en_us&edition=fundamental","pubTime":"2026-04-28 16:59","pubTimestamp":1777366762,"startTime":"0","endTime":"0","summary":"Transcenta issued its 2025 environmental, social, and governance report, outlining a four-tier ESG governance structure led by board and audit committee.Audit committee scope now covers major ESG and climate decisions, with ESG performance linked to senior management remuneration.R&D spend totaled RMB 140.8 million, with 62 R&D staff supporting early-stage oncology and autoimmune programs.Anti-corruption training covered 6 directors, 120 employees; report cited 0 corruption-related lawsuits.Cybersecurity controls delivered 100% remediation of medium-to-high risk vulnerabilities; malware identification and blocking rate rose to over 99.5%.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transcenta Holding Limited published the original c","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDLVchTX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06628","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629870833","title":"Transcenta Therapeutics Presents New Data for Its Novel Liv1-Targeting ADC Tst013 Demonstrating Potent Anti-Tumor Activity in Pdx Models of Prostate Cancer and Er Positive /Her2 Negative Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2629870833","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629870833?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:03","pubTimestamp":1776942192,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nFWN4160AO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06628","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629683380","title":"Transcenta Holding Ltd - ADC-2 Well Tolerated in Mice With Maximum Tolerated Dose of 60 Mg/Kg","url":"https://stock-news.laohu8.com/highlight/detail?id=2629683380","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629683380?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:03","pubTimestamp":1776942192,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nFWN4160AO:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06628","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187613037","title":"TRANSCENTA-B Reveals New Data Showing Potent Anti-Tumor Activity of Novel LIV1 ADC TST013 in Prostate Cancer and ER-Positive/HER2-Negative Breast Cancer PDX Models","url":"https://stock-news.laohu8.com/highlight/detail?id=1187613037","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187613037?lang=en_us&edition=fundamental","pubTime":"2026-04-23 07:06","pubTimestamp":1776899191,"startTime":"0","endTime":"0","summary":"TRANSCENTA-B (06628) announced the presentation of preclinical data for its self-developed LIV1 Antibody-Drug Conjugate (ADC) at the 2026 AACR Annual Meeting. The data demonstrated potent anti-tumor...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","09939","06628","159938","BK4080","BK1161","ADC","BK1574","PDX","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114357235","title":"TRANSCENTA-B presents robust preclinical results for LIV1-targeting ADC TST013 in prostate and ER+/HER2- breast cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=1114357235","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114357235?lang=en_us&edition=fundamental","pubTime":"2026-04-23 07:03","pubTimestamp":1776898982,"startTime":"0","endTime":"0","summary":"TRANSCENTA-B (Transcenta Holding Limited) released updated preclinical data on its proprietary LIV1-targeting antibody–drug conjugate (ADC) programme, TST013, at the 2026 AACR Annual Meeting. The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06628"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629156079","title":"Transcenta presents preclinical TST013 LIV1 ADC data in prostate, ER+/HER2- breast PDX models","url":"https://stock-news.laohu8.com/highlight/detail?id=2629156079","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629156079?lang=en_us&edition=fundamental","pubTime":"2026-04-23 06:58","pubTimestamp":1776898721,"startTime":"0","endTime":"0","summary":"Transcenta disclosed new preclinical findings for its LIV1-targeting antibody-drug conjugate program TST013, scheduled for presentation at 2026 AACR Annual Meeting.Study results showed strong tumor-suppression activity in patient-derived models of ER-positive/HER2-negative breast cancer, supporting potential positioning in a large breast cancer segment.Separate prostate cancer models indicated efficacy depended on payload choice, with one candidate showing more durable tumor control than another.Tolerability work in mice supported continued development, with safety for one candidate described as favorable while the other remains under evaluation.Update signals continued pipeline investment in LIV1-positive solid tumors, with data intended to underpin next-stage development decisions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for info","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDL15bbGq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06628","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":68,"code":"91000000","status":"200"}]}}